Basic Information
Basic information for MIR9-3HG-247-16aa-3
Peptide Name MIR9-3HG-247-16aa-3
Genome Position chr15:89397459-89397506[+]
Species Human
Peptide Sequence MPHTTLPGGRVRLHLP
Peptide Length 16
Unique No (MIR9-3HG-201-16aa-3,MIR9-3HG-212-16aa-3,MIR9-3HG-213-16aa-3,MIR9-3HG-214-16aa-1,MIR9-3HG-218-16aa-1,MIR9-3HG-219-16aa-1,MIR9-3HG-220-16aa-3,MIR9-3HG-221-16aa-3,MIR9-3HG-222-16aa-1,MIR9-3HG-226-16aa-2,MIR9-3HG-227-16aa-1,MIR9-3HG-233-16aa-1,MIR9-3HG-241-16aa-1,MIR9-3HG-246-16aa-1,MIR9-3HG-251-16aa-1,MIR9-3HG-252-16aa-1,MIR9-3HG-253-16aa-1)
Grand Average of Hydropathicity -0.3062
Relative Molecular Mass 2052.44
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000669499;MIR9-3HG-247
Transcript Length 3818
Coding Ability 0.4688
DNA Sequence Corresponding to Peptide ATGCCGCACACCACCCTCCCTGGGGGCAGGGTCAGGCTACACCTGCCT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :